# US 2025/0082468 A1 · Heart valve that includes coating material

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082468 A1
- Document ID: US20250082468A1
- Status: Published application
- Kind: A1
- Application number: 18/401,551
- Filed: 2023-12-31
- Published: 2025-03-13
- Earliest claimed: 2023-09-11
- Assignees: MiRus LLC
- Applicants: MiRus LLC
- Inventors: Jordan Bauman; Noah Roth; Jay Yadav; S. Beckett Gookin; Md Tausif Salim; Jorge Jimenez; Jason White
- Web page: https://patentgrep.com/patent/US20250082468A1

## CPC

- A61F 2/2418: {Scaffolds therefor, e.g. support stents}
- A61F 2/2412: {with soft flexible valve members, e.g. tissue valves shaped like natural valves}
- A61F 2/243: {Deployment by mechanical expansion}
- A61L 27/045: {Cobalt or cobalt alloys}
- A61L 27/047: {Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06}
- A61L 27/06: Titanium or titanium alloys
- A61L 27/306: {Other specific inorganic materials not covered by A61L27/303 - A61L27/32}
- A61L 27/3625: {Vascular tissue, e.g. heart valves}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 31/022: {Metals or alloys}
- A61L 31/088: {Other specific inorganic materials not covered by A61L31/084 or A61L31/086}
- A61F 2210/0076: multilayered, e.g. laminated structures
- A61F 2250/0067: Means for introducing or releasing pharmaceutical products into the body
- A61L 2300/114: Nitric oxide, i.e. NO
- A61L 2420/04: Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
- A61L 2420/08: Coatings comprising two or more layers
- A61L 2430/20: for reconstruction of the heart, e.g. heart valves
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A prosthetic heart valve that is at least partially coated with an enhancement coating, and a method for inserting the prosthetic heart valve in a patient. The prosthetic heart valve includes an expandable frame, a leaflet structure, and optionally an inner skirt and/or an outer skirt. One or more of the components of the prosthetic heart valve can be partially or fully coated with the enhancement coating. One type of enhancement coating that can be used includes titanium oxynitride or titanium nitride oxide (TiNOx) and/or zirconium oxynitride (ZrNxOy).

## Claims

### Claim at position 1

1-54. (canceled)

### Claim 55

A prosthetic heart valve that includes an expandable metallic frame and one or more leaflets; said expandable metallic frame is directly or indirectly attached to said one or more leaflets; said one or more leaflets are configured to at least partially control blood flow through said expandable metallic frame when said expandable metal frame is expanded and inserted in a treatment area of a heart; said expandable metallic frame is partially or fully formed of a) standard stainless steel, b) standard cobalt-chromium alloy, c) standard titanium-aluminum-vanadium alloy, d) standard aluminum alloy, e) standard nickel alloy, f) standard titanium alloy, g) standard tungsten alloy, h) standard molybdenum alloy, i) standard copper alloy, j) standard beryllium-copper alloy, k) standard titanium-nickel alloy, l) refractory metal alloy, or m) metal alloy that includes at least 5 atomic weight percent (awt. %) rhenium; a coating of an enhancement material is a) coated directly on an outer surface of one or more portions of said expandable metallic frame, and wherein a thickness of said enhancement material is less than a thickness of said expandable metallic frame, and/or b) coated directly on an outer surface of one or more portions of said one or more leaflets, and wherein a thickness of said enhancement material is less than a thickness of said one or more leaflets; said enhancement coating is formed of a) a coating material that includes one or more of chromium nitride (CrN), diamond-like carbon (DLC), titanium nitride (TiN), oxynitride, zirconium nitride (ZrN), zirconium oxide (ZrO2), oxyzirconium-nitrogen-carbon (ZrNC), and/or zirconium OxyCarbide (ZrOC) or b) a metallic adhesion layer and a coating material that includes one or more of chromium nitride (CrN), diamond-like carbon (DLC), titanium nitride (TiN), oxynitride, zirconium nitride (ZrN), zirconium oxide (ZrO2), oxyzirconium-nitrogen-carbon (ZrNC), and/or zirconium OxyCarbide (ZrOC), and wherein said metallic adhesion layer is coated on an outer surface of said expandable metallic frame and/or said one or more leaflets, and said coating material is coated on an outer surface of said metallic adhesion layer.

### Claim 56 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein said enhancement material is an oxynitride; said oxynitride is formulated to i) provide nitric oxide while said prosthetic heart valve is positioned in said treatment area of said heart, and/or ii) promote generation of nitric oxide while said prosthetic heart valve is positioned in said treatment area of said heart.

### Claim 57 (depends on 56)

The prosthetic heart valve as defined in claim 56, wherein said oxynitride is a metal oxynitride; said metal oxynitride includes titanium oxynitride and/or zirconium oxynitride.

### Claim 58 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein said coating of enhancement material has a thickness of at least 10 nanometers.

### Claim 59 (depends on 57)

The prosthetic heart valve as defined in claim 57, wherein said metal oxynitride has an oxygen to nitrogen atomic ratio of 1:10 to 10:1.

### Claim 60 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein said enhancement material includes said metallic adhesion layer and said coating material is coated on an outer surface of said metallic adhesion layer.

### Claim 61 (depends on 60)

The prosthetic heart valve as defined in claim 60, wherein said metallic adhesion layer is titanium metal or zirconium metal.

### Claim 62 (depends on 60)

The prosthetic heart valve as defined in claim 60, wherein said metallic adhesion layer has a thickness of at least 1 nanometers.

### Claim 63 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein said prosthetic heart valve further includes one or more of an inner skirt, an outer skirt, and/or sutures.

### Claim 64 (depends on 63)

The prosthetic heart valve as defined in claim 63, wherein one or more of said inner skirt, said outer skirt, and said sutures is partially or fully coated with said enhancement material.

### Claim 65 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein said enhancement material includes no more than 0.1 wt. % nickel and/or no more than 0.1 wt. % cobalt.

### Claim 66 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein said expandable metallic frame includes no more than 0.1 wt. % nickel and/or no more than 0.1 wt. % cobalt.

### Claim 67 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein only a portion or all of said expandable metallic frame includes said coating of said enhancement material.

### Claim 68 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein a portion or all of said expandable metallic frame and said one or more leaflets includes said coating of said enhancement material.

### Claim 69 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein said expandable metallic frame is formed of said refractory metal alloy or said metal alloy that includes at least 15 atomic weight percent (awt. %) rhenium.

### Claim 70 (depends on 55)

The prosthetic heart valve as defined in claim 55, wherein said expandable metallic frame is formed of said standard titanium-nickel alloy or said standard titanium-nickel alloy that includes at least 15 atomic weight percent (awt. %) rhenium.

### Claim 71

A method for repairing a heart valve; said method comprising:
a. providing a prosthetic heart valve that is crimped about a delivery system; said prosthetic heart valve includes an expandable metallic frame and one or more leaflets; said expandable metallic frame is directly or indirectly attached to said one or more leaflets; said one or more leaflets are configured to at least partially control blood flow through said expandable metallic frame when said expandable metal frame is expanded and inserted in a treatment area of a heart; said expandable metallic frame is partially or fully formed of a) standard stainless steel, b) standard cobalt-chromium alloy, c) standard titanium-aluminum-vanadium alloy, d) standard aluminum alloy, e) standard nickel alloy, f) standard titanium alloy, g) standard tungsten alloy, h) standard molybdenum alloy, i) standard copper alloy, j) standard beryllium-copper alloy, k) standard titanium-nickel alloy, l) refractory metal alloy, or m) metal alloy that includes at least 5 atomic weight percent (awt. %) rhenium; a coating of an enhancement material is a) coated directly on an outer surface of one or more portions of said expandable metallic frame, and wherein a thickness of said enhancement material is less than a thickness of said expandable metallic frame, and/or b) coated directly on an outer surface of one or more portions of said one or more leaflets, and wherein a thickness of said enhancement material is less than a thickness of said one or more leaflets; said enhancement coating is formed of a) a coating material that includes one or more of chromium nitride (CrN), diamond-like carbon (DLC), titanium nitride (TiN), oxynitride, zirconium nitride (ZrN), zirconium oxide (ZrO2), oxyzirconium-nitrogen-carbon (ZrNC), and/or zirconium OxyCarbide (ZrOC) or b) a metallic adhesion layer and a coating material that includes one or more of chromium nitride (CrN), diamond-like carbon (DLC), titanium nitride (TiN), oxynitride, zirconium nitride (ZrN), zirconium oxide (ZrO2), oxyzirconium-nitrogen-carbon (ZrNC), and/or zirconium OxyCarbide (ZrOC), and wherein said metallic adhesion layer is coated on an outer surface of said expandable metallic frame and/or said one or more leaflets, and said coating material is coated on an outer surface of said metallic adhesion layer;
b. positioning said prosthetic heart valve in a treatment area of a heart; and,
c. expanding said expandable metallic frame from a crimped state to an expanded state while said prosthetic heart valve is in said treatment area of said heart.

### Claim 72 (depends on 71)

The method as defined in claim 71, wherein said metallic frame has no more than 5% recoil after said expandable metallic frame has been expanded from said crimped state to said expanded state.

### Claim 73 (depends on 71)

The method as defined in claim 71, wherein said metallic frame has no more than 5% longitudinal foreshortening when said expandable metallic frame is expanded from said crimped state to said expanded state.

### Claim 74 (depends on 71)

The method as defined in claim 71, wherein said enhancement material is an oxynitride; said oxynitride is formulated to i) provide nitric oxide while said prosthetic heart valve is positioned in said treatment area of said heart, and/or ii) promote generation of nitric oxide while said prosthetic heart valve is positioned in said treatment area of said heart.

### Claim 75 (depends on 74)

The method as defined in claim 74, wherein said oxynitride is a metal oxynitride; said metal oxynitride includes titanium oxynitride and/or zirconium oxynitride.

### Claim 76 (depends on 71)

The method as defined in claim 71, wherein said coating of enhancement material has a thickness of at least 10 nanometers.

### Claim 77 (depends on 74)

The method as defined in claim 74, wherein said metal oxynitride has an oxygen to nitrogen atomic ratio of 1:10 to 10:1.

### Claim 78 (depends on 71)

The method as defined in claim 71, wherein said enhancement material includes said metallic adhesion layer and said coating material is coated on an outer surface of said metallic adhesion layer.

### Claim 79 (depends on 78)

The method as defined in claim 78, wherein said metallic adhesion layer is titanium metal or zirconium metal.

### Claim 80 (depends on 78)

The method as defined in claim 78, wherein said metallic adhesion layer has a thickness of at least 1 nanometers.

### Claim 81 (depends on 71)

The method as defined in claim 71, wherein said prosthetic heart valve further includes one or more of an inner skirt, an outer skirt, and/or sutures.

### Claim 82 (depends on 81)

The method as defined in claim 81, wherein one or more of said inner skirt, said outer skirt, and said sutures is partially or fully coated with said enhancement material.

### Claim 83 (depends on 71)

The method as defined in claim 71, wherein said enhancement material includes no more than 0.1 wt. % nickel and/or no more than 0.1 wt. % cobalt.

### Claim 84 (depends on 71)

The method as defined in claim 71, wherein said expandable metallic frame includes no more than 0.1 wt. % nickel and/or no more than 0.1 wt. % cobalt.

### Claim 85 (depends on 71)

The method as defined in claim 71, wherein only a portion or all of said expandable metallic frame includes said coating of said enhancement material.

### Claim 86 (depends on 71)

The method as defined in claim 71, wherein a portion or all of said expandable metallic frame and said one or more leaflets includes said coating of said enhancement material.

### Claim 87 (depends on 71)

The method as defined in claim 71, wherein said expandable metallic frame is formed of said refractory metal alloy or said metal alloy that includes at least 15 atomic weight percent (awt. %) rhenium.

### Claim 88 (depends on 71)

The method as defined in claim 71, wherein said expandable metallic frame is formed of said standard titanium-nickel alloy or said standard titanium-nickel alloy that includes at least 15 atomic weight percent (awt. %) rhenium.

### Claim 89

A prosthetic heart valve that includes an expandable metallic frame and one or more leaflets; said expandable metallic frame is directly or indirectly attached to said one or more leaflets; said one or more leaflets are configured to at least partially control blood flow through said expandable metallic frame when said expandable metal frame is expanded and inserted in a treatment area of a heart; said expandable metallic frame is partially or fully formed of a) standard cobalt-chromium alloy, b) standard titanium-aluminum-vanadium alloy, c) standard titanium-nickel alloy, d) refractory metal alloy, or e) metal alloy that includes at least 5 atomic weight percent (awt. %) rhenium; a coating of an enhancement material is coated directly on an outer surface of one or more portions of said expandable metallic frame and one or more portions of an outer surface of said one or more leaflets, and wherein a thickness of said enhancement material is less than a thickness of said expandable metallic frame or said one or more leaflets; said enhancement material includes no more than 0.1 wt. % nickel and/or no more than 0.1 wt. % cobalt; said enhancement coating is formed of a) a coating material that includes one or more of chromium nitride (CrN), diamond-like carbon (DLC), titanium nitride (TiN), oxynitride, zirconium nitride (ZrN), zirconium oxide (ZrO2), oxyzirconium-nitrogen-carbon (ZrNC), and/or zirconium OxyCarbide (ZrOC) or b) a metallic adhesion layer and a coating material that includes one or more of chromium nitride (CrN), diamond-like carbon (DLC), titanium nitride (TiN), oxynitride, zirconium nitride (ZrN), zirconium oxide (ZrO2), oxyzirconium-nitrogen-carbon (ZrNC), and/or zirconium OxyCarbide (ZrOC), and wherein said metallic adhesion layer is coated on said outer surface of one or more portions of said expandable metallic frame and not coated on said one or more leaflets, and wherein said coating material is coated on an outer surface of said metallic adhesion layer that is coated said outer surface of one or more portions of said expandable frame, and wherein said coating material is directly coated on said outer surface of one or more portions of said one or more leaflets, and wherein said metallic adhesion layer is titanium metal or zirconium metal.

### Claim 90 (depends on 89)

The prosthetic heart valve as defined in claim 89, wherein said enhancement material is an oxynitride; said oxynitride is formulated to i) provide nitric oxide while said prosthetic heart valve is positioned in said treatment area of said heart, and/or ii) promote generation of nitric oxide while said prosthetic heart valve is positioned in said treatment area of said heart; said oxynitride is a metal oxynitride; said metal oxynitride includes titanium oxynitride and/or zirconium oxynitride.

### Claim 91 (depends on 90)

The prosthetic heart valve as defined in claim 90, wherein said prosthetic heart valve further includes one or more of an inner skirt, and/or an outer skirt; one or more of said inner skirt and/or said outer skirt is partially or fully coated with said enhancement material.

### Claim 92 (depends on 90)

The prosthetic heart valve as defined in claim 90, wherein said expandable metallic frame includes no more than 0.1 wt. % nickel and/or no more than 0.1 wt. % cobalt.

### Claim 93 (depends on 90)

The prosthetic heart valve as defined in claim 90, wherein said expandable metallic frame is formed of said refractory metal alloy or said metal alloy that includes at least 15 atomic weight percent (awt. %) rhenium
